SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco's Goa Plant I gets statement of GMP non-compliance from UK- MHRA

26 Apr 2018 Evaluate

Indoco Remedies’ Goa Plant I has received a statement of non-compliance and restricted GMP certificate to permit continued manufacture and testing of products considered to be medically critical or to ensure continuity of supply, as determined by the national competent authority.

The MHRA statement also says that, there is no evidence of product having been impacted and therefore the inspectorate does not recommend that the products are recalled.

The company is in communication with the European Health authorities and hopeful of getting early resolution. In the interim, medically critical products will be allowed to be supplied from the affected facility, the list of which is being finalised by MHRA and other National Competent authorities in coordination with the company’s customers.

This will have a temporary impact on the company’s business to Europe, which the company will minimize by transferring products from the affected facility (Goa I) to their other manufacturing facilities (Goa III and Baddi I) holding valid EU GMP certification.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×